Tibet AIM Pharm. Inc.
SZSE:002826.SZ
10.97 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| 47.46 | 15.386 | 46.116 | 43.473 | 41.091 | 37.329 | 25.255 | 60.477 | 55.358 | 50.03 | 33.857 | 21.823 |
| Depreciation & Amortization
| 21.693 | 24.136 | 22.701 | 23.741 | 16.744 | 10.913 | 9.477 | 8.293 | 7.41 | 3.371 | 3.477 | 3.418 |
| Deferred Income Tax
| 0 | 0 | -2.682 | 3.553 | -3.643 | 1.187 | 1.14 | 1.925 | 0.648 | -3.038 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0.325 | 0.532 | 1.635 | 2.034 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -3.965 | 111.58 | 38.877 | 24.786 | 37.97 | 11.083 | -31.754 | 6.728 | -16.156 | -86.634 | -37.884 | 25.534 |
| Accounts Receivables
| -14.568 | 170.437 | 6.105 | 86.187 | -44.794 | -3.215 | -14.206 | -48.912 | -16.289 | -60.727 | -65.69 | 10.88 |
| Inventory
| 17.627 | -13.416 | -12.088 | -12.518 | 8.778 | -0.939 | 5.501 | 1.686 | 8.685 | -16.384 | -2.412 | 3.083 |
| Accounts Payables
| 0 | -46.74 | 47.542 | -52.436 | 77.629 | 14.05 | -24.19 | 52.03 | -9.2 | -6.484 | 0 | 0 |
| Other Working Capital
| -7.024 | 1.298 | -2.682 | 3.553 | -3.643 | 1.187 | -37.256 | 5.042 | -24.841 | -70.25 | -35.472 | 22.452 |
| Other Non Cash Items
| 46.385 | 15.778 | -36.883 | 13.436 | 7.938 | -3.344 | 10.336 | 1.79 | 10.567 | 3.541 | 2.734 | 1.465 |
| Operating Cash Flow
| 111.573 | 166.881 | 68.453 | 109.522 | 101.736 | 59.202 | 13.314 | 77.288 | 57.179 | -29.691 | 2.184 | 52.24 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -12.243 | -3.181 | -3.198 | -25.195 | -38.429 | -170.451 | -67.716 | -74.616 | -18.522 | -44.172 | -45.122 | -28.616 |
| Acquisitions Net
| 0 | 0 | 0.001 | -29.446 | 38.464 | 170.451 | 68.441 | 0.149 | 18.533 | 2.043 | 45.122 | 28.637 |
| Purchases Of Investments
| -490 | -492.142 | -200 | -240 | -90 | -415 | -365 | -330 | -33 | -77.8 | -228.8 | -33.5 |
| Sales Maturities Of Investments
| 521.103 | 452.242 | 201.481 | 240.907 | 120.547 | 386.08 | 368.532 | 332.874 | 33.037 | 80.064 | 212.605 | 16.529 |
| Other Investing Activites
| 0.136 | 0.079 | 0 | 0.057 | -38.429 | -170.451 | -67.716 | 0.81 | -18.522 | 1.901 | -45.122 | -28.616 |
| Investing Cash Flow
| 18.997 | -43.002 | -1.715 | -53.678 | -7.847 | -199.371 | -63.459 | -70.783 | -18.474 | -37.964 | -61.317 | -45.566 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| 11.799 | -39 | 0 | -40 | -30 | 0 | 0 | -10 | -50 | 50 | -10 | 0 |
| Common Stock Issued
| 0 | 0 | -47.358 | 3.009 | 7.493 | 18.148 | 0 | -5.34 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -0.022 | -2.642 | -3.009 | -7.493 | -18.148 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -6.037 | -20.281 | -19.007 | -15.272 | -7.671 | -5.692 | -12.763 | -11.383 | -3.5 | -0.766 | -3.264 | -1.813 |
| Other Financing Activities
| -50.026 | 0 | 49.242 | -0.922 | -1.617 | 45.44 | 40 | -4.828 | 257.987 | 17.432 | 85 | 5 |
| Financing Cash Flow
| -44.263 | -59.303 | 27.592 | -59.203 | -46.781 | 39.748 | 27.237 | -26.211 | 204.487 | 66.666 | 71.736 | 3.187 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0.236 | -0.003 | -0.018 | -0.018 | -0.078 | 0.032 | 0 | -0 | -0.018 | 0.009 | 0 | -0.004 |
| Net Change In Cash
| 86.542 | 64.573 | 94.312 | -3.377 | 47.029 | -100.388 | -22.909 | -19.706 | 243.174 | -0.981 | 12.603 | 9.857 |
| Cash At End Of Period
| 427.398 | 340.856 | 276.283 | 181.971 | 185.348 | 138.319 | 238.707 | 261.616 | 281.322 | 38.147 | 39.128 | 26.525 |